Why is Anthropic planning a major IPO?
How did Trump’s Honduras policy impact aid?
What caused Airbus to cut delivery targets?
Why is copper demand rising for AI data centers?
How will EU gas ban affect energy markets?
Why did Michael and Susan Dell fund Trump accounts?
What led to Tennessee’s special election outcome?
Regeneron Invests $150 Million In Tessera To Advance One-Time Gene Therapy For Rare Genetic Disorder
benzinga.com/news/health-care/25/12/49142541/regeneron-invests-150-million-in-tessera-to-advance-one-time-gene-therapy-for-rare-genetic-disor
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Tessera Therapeutics, Inc., on Monday announced a global collaboration to develop and commercialize TSRA-196.
• REGN is lagging behind market performance. Stay ahead of the curve here.
TSRA-196 is Tessera’s lead investigational in vivo…
This story appeared on benzinga.com, 2025-12-01 17:35:48.